|
|
| Hybrid Systems |
|
|
First Invested:
Amount Invested:
Sector:
Web:
|
December 2000
£250,000
Biotechnology
www.hybridsystems.co.uk
|
| Based on technology from Birmingham University, Hybrid Systems Ltd. is exploiting the interface between polymer chemistry and biology to generate new products and tools for applications in areas as diverse as gene therapy, vaccination, agriculture and bioremediation. The company's principal technology enables simple, non-genetic coating of viruses, bacteria and spores, using hydrophilic polymers, to create safer and more versatile biological agents. There are several valuable applications of this platform technology and this has been validated through commercial collaborations. The company's primary focus is currently in the area of cancer therapy. The versatile polymer-coated viral and non-viral biological agents that have been generated are effective at evading immuno-detection and can be targeted to specific cells and tissues by incorporation of specific cellular receptor-binding moieties. |
back to Our Portfolio
|
|
